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Abstract 16 
Background: Pharmacists and healthcare professionals are faced with increasing and changing health 17 
care needs around the world. In order to meet these demands, they are required to continuously 18 
upgrade and develop their professions.Reprofessionalization drives are therefore crucial to the 19 
successful delivery of health services, but traditional theories of the professions provide little practical 20 
guidance to evaluating the overall status of a profession.  21 
Objective: This study proposes a new conceptual framework of three interrelated professional sectors: 22 
education, regulation and practice, and uses it to identify and analyse challenges facing the pharmacy 23 
profession in Jordan.  24 
Methods:A multiple-method qualitative study comprised of semi-structured interviews and focus 25 
groups was conducted in Amman, Jordan. To explore and identify the challenges, apurposively 26 
recruited cross-sector sample of fifty-three key informants, stakeholders and pharmacists were 27 
interviewed. Interview transcripts were translated and then analysed using QSR NVivo 10. Thematic 28 
analysis identified eight main challenges facing pharmacy in Jordan. The original participants were 29 
then invited to participate in focus groups, the purpose of which was to validate the interview 30 
findings, map them against the conceptual framework and discuss recommendations for development.  31 
Results:The eight validated challenges span the following areas: graduates preparedness for practice, 32 
pharmacy education accreditation and quality assurance, pre-registration requirements, workforce 33 
development, workforce planning, remuneration and wage rate, pharmacy assistants, and PharmD 34 
pharmacists. Focus group participants used the framework to map each of the challenges to the 35 
primary sector-to-sector disconnect that they perceived to explain it. A list of recommendations 36 
addressing each of the challenges was also devised.  37 
Conclusions:The framework was found to offer valuable insight as an explanatory and diagnostic tool 38 
in policy-relevant research. By emphasizing the processual and contextual nature of 39 
reprofessionalization, the framework presents an alternative approach to traditional theories. This 40 
study also raises important questions regarding the status of pharmacy in Jordan and aims to provide 41 
guidance for local development and much-needed reprofessionalization drives. 42 
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Introduction 47 
Sociological theorists have long been interested in the theory of professions and what distinguishes 48 
them from other occupations. According to an early idealistic ‘normative’ approach to defining a 49 
profession, values and ethical codes give the professions their key stabilising function in society
1,2
;but 50 
this categorization of an occupation –largely based onunsubstantiated privilege granted by society – 51 
was not deemed a sufficient measure for discriminating between occupations.
3,4
The argument was 52 
therefore further expanded by the ‘trait’ approach to include, in addition to a code of ethics, a 53 
combined range of defining characteristics or traits (e.g. self-regulation, training, licensing, 54 
examinations, and professional associations)
5,6
; thevaried interpretationsof the trait approach and its 55 
arbitrarily setlists of criteria explainits failure to produce a consensus.
4
 Interactionist views,on the 56 
other hand, examine the dynamics of professionalism as a form of service provision rather than a set 57 
of traits; this ‘occupational control’ approach argues that professionals deploy exclusive services to 58 
exert market control over their occupation.
3,7,8
Freidson proposed that in addition to this occupational 59 
control or ‘dominance’, ‘autonomy’– or the ability to control one’s workactivities –is also needed to 60 
giveprofessional power to an occupational group.
9
 Sceptics, however, attribute the narrowing of 61 
knowledge gaps and the rise of new and highly-specialised occupations to the decline of these 62 
professional powers.
10,11
Within the theories of professions, there appears to be no unified holistic 63 
approach to what constitutes the professionalization of an occupation – or the process of it becoming a 64 
profession.  65 
Professionalization and pharmacy 66 
Throughout these ongoing disagreements, debates and theoretical evolutions, the profession of 67 
medicine – firmly rooted in the historic Hippocratic Oath – has always been “the example of choice 68 
when sociological theories about the professions were discussed”.12As the division of healthcare 69 
labour progressed, the professionalization of pharmacy and other healthcare occupations beganto 70 
increasingly feature in such discussions.
3,13,14
The story of the professionalization of pharmacists is set 71 
within the evolutionary stages of pharmacy practice models. Manufacturing, compounding and 72 
distributing medicines were key features of practice in the 19
th
 century; the establishment of sale and 73 
supply restriction laws, pharmacy schools and representative associations across Europe, the U.S and 74 
Asia signalled the start of professional regulation, official representation, and organized education of 75 
pharmacy.
15
 The large loss of pharmacists’ manufacturing and compounding roles to the advent of the 76 
20th century pharmaceutical industry was coupled with the consequential loss of their social purpose 77 
as compounders and distributers; hospital pharmacists had more varied activities but as in community 78 
practice, the emphasis shifted to the ‘product’.16 These events coincided with pharmacy beginning to 79 
feature in discussions- albeit with negative connotations- on sociological theories of the professions.  80 
Despite pharmacists gaining occupational control over their service through preventing the 81 
unqualified from dispensing medicines, the pharmacy profession has historically been considered 82 
subordinate to the medical profession and its professional status has often been questioned. In his 83 
1964 essay,‘The Professionalization of Everyone?’, Wilensky critically examines the “heroic 84 
struggles” of some occupations to join the rank of “clearly recognized and organised” professions and 85 
describes pharmacy as a “borderline” profession ancillary to medicine.13 Medical sociologists Denzin 86 
and Mettlinsimilarly argued for the “incomplete professionalization”of pharmacists and partly owed 87 
their allegedly failed “attempt to turn themselves from ordinary occupations into the prestigious 88 
groupings called professions” because of their lack of control on medicine, their social 89 
object.
17
Freidsonalso agreed by concluding that pharmacy is “firmly subordinated to medicine”due to 90 
the inability of pharmacists to diagnose diseases and prescribe medicines,which compromises their 91 
professional ‘autonomy’ according to him.9However, the provision of drug information and 92 
medication counselling by community pharmacists and the addition of clinical pharmacy to hospital 93 
settings would eventually redefine the essence of practice and somewhat neutralise the negative 94 
effects of the manufacturing industry.
16
These developments formed the backdrop to the introduction 95 
of Hepler and Strand’s concept of pharmaceutical care.18Shortly after, Dingwall and Wilsonfirmly 96 
reject Denzin and Mettlin’s claims,counter-arguing that pharmacy’s social object is not the medicine 97 
itself butrather its median role for social change.
19
Despite these developments, the ‘quasi’-status of 98 
pharmacy as a profession –as defined by the traditional sense of the word – still holds in 99 
contemporary literature.
20,21
 100 
Towards a new approach 101 
The field of health professions is not static and shifts continuously as health care systems and the role 102 
of health care professionals develop and adapt over time; and many of the assumptions underlying the 103 
traditional professions theories do not survive the dynamic climate of health care.
4
 Pharmacists are 104 
continuously faced with increasinglydemanding and complex healthcare needsand advancing 105 
technologies,forcing them to constantlyre-evaluate their current practice modelsand envision future 106 
ones.
22
According to Birenbaum
23
,these continuous efforts to upgrade and develop the status of 107 
pharmacy within changing health care environments is referred toas reprofessionalization.Reform 108 
drives in the name of reprofessionalization have become a recurring feature of literature; the topic is 109 
examined through several lenses such as extending practice roles
20,24,25
, advancing educational 110 
models
26-28
, and reviewing existing regulatory systems.
29,30
Birenbaum concedes that theoretical 111 
frameworks “fail to recognize the interactive and contextual nature of the development of the 112 
professions”.23According to Annandale31, the relationship between theory and research is also 113 
reciprocal where “extant theories gradually fall out of fit with societies as they change and new 114 
approaches are called for”. This presents a structural problem for research aiming to identify 115 
challenges affecting the advancement of a profession andto assess if it’s time to reprofessionalize an 116 
occupation, without relying on or associating withephemeraldefinitions that supposedly determinesits 117 
professionalization. The paper presents an alternative approach to the traditional theories of the 118 
professions and professionalization. It describes a simple conceptual framework that redefines what 119 
constitutes a professional arena and test it in a case study conducted on pharmacy in Jordan.   120 
The conceptual framework 121 
The conceptual framework describes that in any professional arena, there is a dynamic and complex 122 
interplay between the education, regulation and practicesectors. The framework was developed by 123 
author Michael J. Rouse in the early 2000’s as a result of his work with the Accreditation Council for 124 
Pharmacy Education (ACPE), the U.S. national accreditation agency for pharmacy education. The 125 
conceptual framework, used widely in presentations, was intended to depict the separation of the 126 
entities responsible for education, practice and regulation, but at the same time the dynamic 127 
relationships that exist between the sectors, working in collaboration to advance the profession. It was 128 
first published in Version 1 of the Global Framework for Quality Assurance of Pharmacy Education – 129 
adopted by the International Pharmaceutical Federation (FIP) in 2008. FIP is the largest global body 130 
representing pharmacy and pharmaceutical sciences and whose goal is to support the development of 131 
the pharmacy profession. Figure 1 illustrates the relationship between the three principal components 132 
of the framework. ‘Practice’ refers to the sector of the profession that provides a broad range of 133 
services to society in and from a variety of settings. ‘Regulation’ refers to the sector – within and/or 134 
outside the profession – that determines and enforces the statutory requirements for the organization 135 
and practice of pharmacy. ‘Education’ refers to the sector of the profession that prepares the members 136 
of the pharmacy workforce for practice; i.e. both pre-service education and continuing education (CE) 137 
/continuing professional development (CPD). 138 
 139 
Figure 1 A conceptual framework depictingthe dynamic relationships between practice, regulation and education. 140 
(International Pharmaceutical Federation 2014, adapted with permission) 141 
The framework depicts that there should exist a dynamic relationship between its components or 142 
sectors – even a ‘tension’– constantly driving change and advancement. The separation also provides 143 
for ‘checks and balances’ whereby a ‘push’ from one side can be checked (even opposed) by the other 144 
sector, with some positioning back and forth until something that works in the best interests of the 145 
profession and the public becomes the agreed ‘end point’.The possible negative impact of a lack of 146 
separation (the absence of checks and balances) between these three sectors may lead to stagnation or 147 
conflict-of-interest; ‘self-regulation’, for example, can be used to illustrate this effect and will be 148 
discussed in this paper.At the same time, however, it is important to ensure that at no stage do any of 149 
the separations depicted get too wide, thereby creating a disconnect, which may lead to dissatisfaction 150 
or frustration. If, for example, pharmacy educators teach for a model that is not supported by 151 
practitioners and/or regulators, graduates may become disillusioned if the practice or regulatory 152 
environment does not allow them to practice in the manner conveyed by the academic programme. 153 
Developments and innovations in any of these professional domains may lead, drive or require an 154 
appropriately measured response from another, but there must always be that dynamic interplay of 155 
‘checks and balances’.Failure to make needed changes by one sector can – and should be – challenged 156 
by the other sectors in the profession. For example, changes in practice needs may force appropriate 157 
changes to be made in education, and new regulations will impose new effects on the practice 158 
environment. A proper push-pull fit between these professional domainsis crucial to not only 159 
maintaining the integrity of the profession, but to also advancing it. Similarly, any disconnect between 160 
them destabilises their harmony and may prove, to varying degrees, detrimental to the overall state of 161 
the profession.Existing challenges hindering the advancement of a profession may also be better 162 
understood by tracing them back to their corresponding ‘disconnected’ axes;for instance, 163 
noncompliance to dispensing laws can be traced to a primary disconnect between ‘regulation’ and 164 
‘practice’ owed tothe weak implementation of dispensing regulations in community practice. This 165 
additional diagnostic or formative feature of the framework allows it to be a practical analytical tool 166 
in policy-relevant prescriptive studies. 167 
The pharmacy scene in Jordan 168 
Modern pharmacy practice in the Hashemite Kingdom of Jordan – or Jordan –can be traced to the 169 
1930s and the first independent community pharmacy opened in 1946.
32
 The Jordan Pharmaceutical 170 
Association (JPA) was established in 1957but the JPA Law 1972 was the primary legislation that 171 
enabled its present role asa statutory regulatory and registration body;in addition, the JPA also acts as 172 
the principal professional body representing, promoting and developing the pharmacy profession in 173 
Jordan. The regulation of pharmacy in Jordan is a complex amalgam of statutory frameworks carried 174 
out by separate entities but one that can be broadly categorized as state-sanctioned self-175 
regulation.
3
Pharmacy practice is governed by the JPA’s Drug and Pharmacy Law 2001and the 176 
Ministry of Health’s Public Health Act 2008, Narcotic Drugs and Psychotropic Substances Law 1988 177 
and various sets of statutory rules. The registration of pharmacy premises and the inspection of 178 
medicines and medical devices are the administrative responsibilities of the Ministry of Health and 179 
Jordan Food and Drug Administration, respectively. The JPA defines the pharmacist as “any person 180 
holding a degree in pharmacy from an accredited university in the Kingdom, and registered in the 181 
pharmacists register with the Association and authorized by the Ministry to practice this profession”.33 182 
Registration with the JPA is thus mandatory and pre-registration requirements include the successful 183 
completion ofan accredited pharmacy degree, 1440 hours of training and the JPA’s licensing 184 
examination. There are currently 15 universities in Jordan that offer the five-year Bachelor of Science 185 
(B.Sc.) in Pharmacy and two of them also offer a six-year Doctor of Pharmacy(PharmD) degree;the 186 
B.Sc. is considered the main national programme, but both degrees qualify as an entry requirement 187 
and are accredited by the Higher Education Accreditation Commission (HEAC).
34
 To maintain their 188 
registration status, pharmacists are required to pay annual fees to the JPA. There are no mandatory CE 189 
or CPD requirements of pharmacists, nor are there any post-licensure revalidation mechanisms in 190 
place. The majority of pharmacistswork in the private sector
35
, and the various practice settings in 191 
Jordan include community pharmacies, hospital pharmacy, the manufacturing industry, 192 
pharmaceutical wholesalers and distributers (locally referred to as drugstores), academic institutions, 193 
professional and regulatory bodies, research and consultancy companies as well as other 194 
governmental and intergovernmental organisations.  195 
At face value, pharmacy in Jordan is thriving: (1) Jordan is aleading global pharmaceutical industry 196 
exporter andregional medical tourism destination
36,37
;and (2) in the decade leading up to 2015, the 197 
number of community pharmacies increased by 50%, exceeding 2200 pharmacies,(3) the total number 198 
of licensed pharmacy schools have doubled bringing the total to 15 (5 public and 10 private), and (4) 199 
the active workforce has also nearly doubled toabout 12,000 pharmacists.
32,38
Underlying these 200 
quantitative growths, concurrently published literature on pharmacy practice paints a less bright 201 
picture and reports a number of challenges. Despite community pharmacies being considered the most 202 
accessible health care facility
32
,pharmaceutical care provision in Jordan continues to suffer from 203 
limitations.
32,39
Community pharmacists fully support the concept of pharmaceutical care,but a number 204 
of barriers to its implementation have been reported such as inadequacies in pharmaceutical care 205 
training and poor physician-pharmacist communication.
40
Despite the introduction of the patient care-206 
oriented Pharm D programme in 2000 , these concerns are also echoed in the hospital settingwhere the 207 
importance of the role of pharmacists in hospital settings is still questioned among physicians in 208 
Jordan who view pharmacists within the traditional role and resist accepting or recognising newer 209 
pharmacy clinical services.
41
 The negative dynamics of the pharmacist-physician relationship have 210 
also been identified as a factor resulting in stress and low job satisfaction among a cross-sector sample 211 
of pharmacists;other factors were reported to be the lack of formal career progression and 212 
development due in part to the absence of CPD/CE.
42
Additionally, a poor public image of the 213 
pharmacist
32
, limited pharmacist-patient interactions
43
,and deficiencies in pharmacists’ 214 
communication and patient counselling skills have been found.
44
The non-strict enforcement of 215 
regulations in pharmacy practice has also been documented;existing classification and dispensing 216 
laws are not strictly enforced and, as such, patients can buy any medication without prescription – 217 
with the exception of controlled narcotics and major tranquilisers.
32
One study also reported that it is 218 
not uncommon to find unsupervised pharmacy assistants unlawfully running pharmacies and 219 
supplying medications to patients.
45
This absence of strict enforcement of dispensing laws not only 220 
sheds light on a regulations problem, but also means that pharmacists and pharmacy assistants are 221 
entrusted with an unofficial but common responsibilityof ‘prescribing’that is outside of the realm of 222 
their expertise.
46
This example demonstrates thatthese and other unknown problems found in 223 
pharmacy in Jordan are not merely a professional and status concern, but are potentially detrimental to 224 
the health and safety of the public.Therefore, understanding the underlying patterns leading to these 225 
issues as well as identifying any other challenges in Jordan is a priority area for investigation.   226 
Purpose of this study 227 
The present study is the first attempt at filling the gaps by identifying the key challenges that are 228 
currently hampering the advancement of the pharmacy profession in Jordan. Using Jordan as a case 229 
study, the authorsincorporated the conceptual framework into the study’s design and analysis, and 230 
examinedits value as an explanatory and formative tool for understanding the uncovered challenges 231 
and devising needs-based strategies to address them. The authors use the experiences from theirmulti-232 
method, participant-centric research approach to discuss the framework’s benefits and implications 233 
for reprofessionalization drives by researchers and stakeholders.   234 
Methods 235 
Study design and setting 236 
Qualitative research generates rich information and is ideally suited for exploratory studies of under-237 
researched topics such as this one
47
, and multiple-methods are particularly recommended for policy-238 
relevant social pharmacy research.
48
This qualitative study was conducted in Jordan’s capital city, 239 
Amman, and adopted a multiple-method approach comprised of semi-structured interviews and focus 240 
groups. The interviews were conducted between October 2013 and May 2014 and their purpose was 241 
to explore and identify the challenges facing pharmacy in Jordan. The focus groups were carried out 242 
in May of the following year; original participants from the interview stage participated in the focus 243 
groups to validate the interview findings and map them against the conceptual framework. LRB 244 
recruited participants, collected all data and conducted the validation focus groups. LRB, CL and SM 245 
were involved in the analytical process. This project received approval from the ‘anonymised’. 246 
  247 
Study participants 248 
A sample of fifty-three key informants, relevant policymakers and pharmacy professionals were 249 
recruited. A purposive snowballing sampling approach was employed to enhance sample coverage 250 
and facilitate access
49
, the latter of particular pertinence in a culture that relies heavily on social 251 
connections and influential intermediaries and where informal and formal gatekeepers play a crucial 252 
role in recruitment.
50
 The participants spanned all sectors of Jordanian pharmacy practice: community 253 
pharmacy (both independent and chain), hospital pharmacy, the manufacturing industry, the academic 254 
sector (i.e. pharmacy schools), professional and regulatory bodies (e.g. JPA), research and 255 
consultancy companies (e.g. clinical contract research, training and development), and governmental 256 
and intergovernmental organisations (e.g. Ministry of Health, HEAC). Table 1 lists the number of 257 
participants by sector. Recruited participants included individuals with senior and middle 258 
management positions (e.g. business owners; sector representatives; deans) as well as employees (e.g. 259 
recent graduates; practitioners; public servants). All but 7 of the participants are pharmacists by 260 
background and 29 (55%) of them female. 261 
 262 
Sector Number of participants 
Community  7 
Hospital  3 
Manufacturing industry 3 
Wholesale and distribution (drugstores) 12 
Academia  8 
Professional and regulatory bodies  5 
Research and consultancy  6 
Governmental and intergovernmental organisations 9 
Total 53 
Table 1Sector distribution of study participants. 263 
  264 
Data collection 265 
The data was collected by the lead author, LRB, a Jordanianpharmacist and doctoral researcher who 266 
received training in qualitative data collection. Potential participants were initially contacted by phone 267 
and invited to take part in the study. Arrangements were made with those who agreed and the 268 
interviews were usually conducted at the participants’ place of work. Before commencing the 269 
interview, every participant was given aninformation sheet about the study and a consent form to read 270 
and sign, respectively. The interviews were audio-recorded and field notes were also taken. The 271 
interviews were semi-structured and participants were asked open questions about challenges they 272 
face in their respective practice area(s), their views on pharmacy education and graduate preparedness 273 
for practice, and their opinions regarding the current state of the profession and its leadership (see 274 
Appendix 1). A semi-structured guideprovided a balance between respondent freedom and 275 
interviewer control and was ideally suited for the exploratory aims of the interviews.
51,52
To maximise 276 
her reflexivity, LRB completed a self-reflection formalmost immediately after eachinterview;the 277 
researcher critically reflected on her interaction with every participant noting her thoughts, feelings 278 
and decisions as researcher and interviewer and acknowledging her centrality to the research.
53,54
In 279 
providing an auditable record of the research process, such reflective practices are usedto maintain 280 
transparency and methodological rigour.
55,56
Reflective writing alsohelped in detecting re-emergent 281 
themes and assisted the researcher in recognisingtheoretical saturation and eventually determining 282 
sample size.
57
The point of saturation, or when no new information was obtained from data collection, 283 
was reached after the 50
th
 interview; no new ideas emergedfrom thefollowing three interviews.
58
  284 
Data translation 285 
The interviews were conducted in the source language (Arabic). Because LRB was the only one in the 286 
research team to share the same language and culture as the participants, translating the interviews to 287 
the target language (English) wasnecessary for the involvement of the rest of the team in analysing the 288 
data and disseminating the findings. Effective translation in cross-language research is critical to the 289 
interpretation of the data and integrity of the results and steps to ensure the conceptual equivalence of 290 
the translations were taken.
59,60
Interview recordings were transcribed verbatim by an assigned local 291 
transcriber who is familiar with pharmaceutical terms;LRBchecked the transcriptsfor accuracy before 292 
forward translating them (from Arabic1 to English1). A translation lexicon or glossary of key and 293 
recurring words was devised to ensure consistency throughout the process
59
;it was certified by a local 294 
professional translator. Back-translation is one of the most common and highly recommended 295 
methods of evaluating conceptual equivalence between source and target versions.
61,62
Therefore ten 296 
full transcripts of the translated interviews were randomly selected and back-translated (from English1 297 
to Arabic2)by an independent bilingual pharmacist and researcher; at least one interview was selected 298 
from every sector group.LRB and the back-translatorcompared the back-translations (Arabic2) with 299 
the original transcripts (Arabic1) to assess whether there was any loss of equivalence or 300 
misinterpretation during theintial translation.After conducting the review, both the researcher and 301 
back-translator found no discrepancies and agreed that the back-translations accurately reflected the 302 
original meanings of the text. The researchers (LRB, CL, SM)decided that there was no need for 303 
further translation verification measures. 304 
  305 
Data analysis 306 
The translated interview transcripts were analysed thematically using the qualitative data analysis 307 
software NVivo 10. The thematic analysis followed the six steps laid out by Braun and Clark: (1) 308 
familiarizing oneself with the data, then (2) generating the initial codes, followed by (3) searching for 309 
themes, (4) reviewing them, (5) naming and defining them, before finally (6) writing-up the 310 
report.
63
Initial coding of the entire data set was carried out by LRB who has familiarized herself with 311 
the interview data through translating them, checking the transcripts against the audio-recordings, 312 
reading and rereading the transcripts, and noting down her initial ideas. The initial codes were 313 
produced in an inductive manner, meaning they weredriven by the data and not by any pre-314 
existingcoding frames or theories.To reduce the risks of subjectivity, multiple-coding was 315 
employed
49
;CL and SM separately analysed segments of text and checked them against the initially 316 
assigned codes to identify any disagreements and to further refine the coding framework. LRB 317 
collated the codes into potential themes, and the three researchers met on several occasions to discuss, 318 
review and name the themes; a thematic map was generated and used throughout these discussions to 319 
illustrate the themes and their relationships and check whether they work consistently with coded 320 
extracts and the overall data set.During the last comparison of analyses, the researchers all agreed 321 
upon a final set of eight themes, with each theme representing a separate challenge area. The 322 
challenges were summarised in preparation for participant validation.  323 
Data validation and mapping 324 
‘Participant or respondent validation/follow-up’, ‘backtalk’ or ‘member checking’: all describe the 325 
process of “cross checking research findings with participants”.49Participant validationhelps maintain 326 
the analytic rigour of the research process, refine explanations, display participant respect, and ensure 327 
the continuity of stakeholder-engagement (especiallysignificant in policy-relevant research sensitive 328 
to de-contextualisation).
57,64-66
Participant validation was carried out in this study to primarily assess 329 
whether the researchers’ interpretation of the data are true to the participants’ perceptions, thereby 330 
increasing the interpretive validity of the study.
67
 Individually reporting results to participants 331 
presented several time and resource constraints so the use of focus groups was deemed the most 332 
logistically effective and methodologically complementary form of generating collective participant 333 
feedback. Email invitations were sent to all 53 participants inviting them to participate in the focus 334 
groups. A total of 13 (25%) participants took part in two focus groups(n1=6, n2=7); both sessions ran 335 
in the same order (see Appendix 2). LRB presented and described the 8 challenges.Every challenge 336 
was then discussed among the group to validate its accuracy in terms of whether they think it fairly 337 
and reasonably represents the situation as they perceive it.
68
 Both groups validated the identified 338 
challenges and agreed that no changes, omissions or additions were needed. Participants were then 339 
asked to take part in an exercise in which each of them was handed a printout sheet with an enlarged 340 
image of the conceptual framework (identical to that in Figure 1.1). A numbered list of the challenges 341 
was displayed on a large screen. They were then asked to assign each challenge to the axis they 342 
believed reflected the primary disconnect leading to it. To ensure their understanding of the task, 343 
several fictional examples were presented before commencing the exercise. This form of mapping 344 
offered a creative and participant-centric means to ground the participants’ perceptions within the 345 
framework.
69
 After completing the activity, the researcher facilitated a group discussion in which the 346 
participants’ answers on each challenge were discussed and debated.Additional attention and time was 347 
especially given to answers contradictory to the majority. Discussions continued untilunanimous 348 
agreement was reached on the most suitable answer, and complementary solutions and 349 
recommendations were proposed and collated. A secondary aim of this participant validation process 350 
was to allow the participants to raise any relevant professional issues or updates that may have 351 
developed in the time elapsed since their interviews. Some participants shared new information about 352 
the scene in Jordan (e.g. upcoming law changes), but no new major themes emerged and the list of 353 
challenges was retained.  354 
Results 355 
Interview findings 356 
Thematic analysis of interview data resulted in eight major themes describing the following challenge 357 
areas: graduates preparedness for practice, the quality assurance and accreditation of pharmacy 358 
education, pharmacy pre-registration requirements, workforce development, workforce planning, 359 
pharmacist remuneration and wage rate, pharmacy assistants, and PharmDpharmacists.   360 
Challenge area #1: graduatespreparedness for practice 361 
The participants, and particularly employers from across all sectors, reported that recent pharmacy 362 
graduates – or newly registered pharmacists – are generally unprepared for practice, citing a gap in 363 
implementation between theory and practice as the main factor. According to a training and 364 
development manager of a pharmacy chain:“There is a very huge gap between here [practice] and 365 
there [education], and there is a gap between pure scientific information and translating it into 366 
benefits and features for the customer.”Onemanager at a wholesale and distribution company 367 
similarly describes this issue: “There is no link between science and business. That’s very clear and 368 
we can see this when we conduct our interviews [with graduates].” A newly registered pharmacist 369 
who works in wholesale and distribution also captured this: “They [pharmacy schools] need to 370 
incorporate practice more which is a very important aspect for pharmacy.”There is a general 371 
consensus that this issue is mainly linked to the quality of the taught curricula which was described as 372 
being traditionally science-focused and largely theory-based. Employers also reported a number of 373 
skills that they perceive as generally lacking from the graduates they come across. All sectors 374 
complained of gaps in interpersonal skills (e.g. communication skills) as well as analytical and critical 375 
thinking skills.In community, patient counselling was also lacking. The industry and regulatory affairs 376 
sectors mainly report shortages in practical knowledge in laboratory analytical skillsand technical 377 
knowledge on basic regulatory and drug registration concepts, respectively. A wholesale and 378 
distribution sector representative illustrated this: “The skills or knowledge that the student acquires in 379 
this field [regulatory] is very superficial. It doesn’t give room for the student, after five years of 380 
university- and five years is a long time- to even know what his or her future career specialty or main 381 
orientation is.” This additional aspect of the lack of career direction or awareness of the different 382 
pharmacy sectors was also reported by a number of the participants who claim that this explains why 383 
many new pharmacists often switch between a range practice settings and jobs upon entering the 384 
market.   385 
Challenge area #2: pharmacy education accreditation and quality assurance 386 
Academics highlight a different challenge in the field of pharmacy education. Pharmacy schools 387 
deans describe the current curricular accreditation standards imposed by HEIAC to be restrictive with 388 
a science-centric scope, resulting in rigid,science-based curricula.This effect was described by a 389 
private school dean as: “There are decent systems in higher education that the Accreditation 390 
Commission put to conserve the reputation of higher education and preserve these specialities. 391 
Unfortunately, on the other hand, there are some restrictions that hinder the freedom of the way 392 
deans and stakeholders should think about developing the programmes.” There is also a reported 393 
variation in the way private and public schools undergo accreditation and quality assurance (QA); 394 
with private schools apparently subject to stricter processes while regulations are somehow more 395 
‘relaxed’ for their public counterparts. Another private school dean reported this as: “If I want [the 396 
curriculum] to be unique in anyway, I can’t because the accreditation won’t allow me. So the 397 
accreditation standards are enforced on me and the other schools, but the public schools are exempt 398 
for an unknown reason.”A HEIAC spokespersoncountered this: “We enforce our standards on 399 
everyone but the public universities have excuses, one of which is the admission system they have. The 400 
[student intake] numbers come to them through the Ministry of Higher Education, so the numbers are 401 
enforced upon them. For example, if the university requests 2000 students, they are sent 4000. So how 402 
can I apply the same restrictions?” Another topic discussed by participants, both academics and non-403 
academics, was The Pharmacy Assistant Bridging Programme (PABP). The PABPallows a Pharmacy 404 
Assistant Diploma (PAD) holder to enrol into a Bachelor of Pharmacy programme. Participants 405 
reported that the admission processes of the PABP and PAD arecommonly known to be unregulated, 406 
allowing individuals who did not meet the stipulated entry requirementsto enter the programmes and 407 
eventually the profession. Some participants view the entire PABP as a threat to the profession; one 408 
drugstore owner expressed this strong opposition to it as: “They need to stop the Bridging! Why can’t 409 
the nurse study further and become a doctor, or the surveyor an engineer?!Why are they allowed to 410 
become pharmacists?!”  411 
Challenge area #3: pre-registration requirements 412 
Participants expressed alarmed concern about the organization and regulation of pre-registration 413 
training.One chief operating officer of a pharmacy chain described this as: “Training is the number 414 
one major issue on which there is hardly any focus and there is barely any regulation. It’s extremely 415 
unorganized and there is no follow-up and it’s harming them [the trainees].”Others described how it 416 
is widespread practice – and common knowledge –for pre-registration trainees not to complete their 417 
mandatory 1440 hours of training. Trainees are required to provide evidenceto the JPA that they’ve 418 
completed their training to be able to register, and this is usually done by providing a signed statement 419 
(or more if conducted in more than one site) from the supervising pharmacistconfirming the number 420 
of hours the trainee completed. It was reported that the forging of training statements is common 421 
practice. One recent graduate who works as a community pharmacist illustrates this: “Some people 422 
tell you: ‘Don’t worry, I can arrange it [the statement] for you.’ So you say to yourself, why should I 423 
do the training? They need to be more strict when it comes to pre-registration training; because no 424 
one trains. None of us trained. Because if we had actually trained, we would have entered the 425 
workplace with some understanding; it would have made a difference.” This is not a new 426 
phenomenon; a vice president of a drugstore reflected: “Training should be more controlled. I 427 
remember even back when I graduated the training wasn’t so controlled and anyone can sign a 428 
training slip without actual training, to be honest. We just had to get a pharmacist’s signature.” There 429 
are currently no official training frameworks or validation mechanisms in place; but a JPA 430 
spokesperson explained that the introduction of the pre-licensing examination in 2011 was in part a 431 
responsive measure to this training issue and is its aim is to filter out unqualified pharmacists: 432 
“Whether they trained or not, whether the statement is real or fake, if they pass the exam, then at least 433 
they know something. They must have walked into a pharmacy during their lives.”The examination is 434 
not viewed as a rigorous entry requirement though.According to a managing director of a drugstore, 435 
“It’s a very simple one. It should be a proper exam, one that would require them to revise everything 436 
they’ve studied. Because you want to guarantee that those who enter the market are of quality and 437 
qualified. Other than that, the reputation of the profession will be ruined and so will be the market.” 438 
Challenge area #4: workforce development 439 
The fourth theme emerged from an issue that was commonly recurring in the interviews: the complete 440 
absence of mandatory CPD and/or CE requirements of pharmacists,as well as of any post-licensure 441 
revalidation systems. A senior pharmacist and researcher from the Ministry of Health (MoH) 442 
described this as: “There is no national mandatory continuing pharmacy education system. We have 443 
no re-licensing processes. My license could be 50 years old without a change. The medics on the 444 
other hand have a Higher Medical Council that regulates continuing education. We are fighting and 445 
battling to have a similar pharmacy council that would stipulate systems for continuing education.” 446 
There is significant frustration with the situation, with considerable blame directed at the JPA for not 447 
taking measures to ensure its members’ fitness to practice. A director working in the manufacturing 448 
industry captures this frustration: “The JPA should have a stronger role. We have been talking about 449 
continuing education for about a million years now!”Another MoH pharmacist voiced herdiscontent: 450 
“This [lack of CPD] is the first big flaw! And whose responsibility is this? The JPA’s!”Pharmacists 451 
have been actively calling for the establishment of a JPA-commissioned pharmacy board or council 452 
that would address and oversee the issue. According to the JPA, systemic bureaucracyand difficulties 453 
in implementing legislative measures have been to blame for the lack of tangible progress by its 454 
existing CPD/CE Working Committee; a spokesperson explained: “Unfortunately it’s taking a lot of 455 
time because it needs... It’s a law by itself so it needs legislation. That’s the part we’re working on; 456 
unfortunately it’s going to take a long time.”Private sector employers have taken initiatives involving 457 
the creation and deployment of in-house assessment systems; a community pharmacy training 458 
manager illustrated an example: “Our problem in the country is that we don’t have any certification 459 
body to certify your license; once you’re licensed, you’re licensed… So you feel that there is no 460 
difference between those who had just graduated and what they’re like ten years after graduation, 461 
which is a disaster. The pharmacist is not developing. So to keep up with that, we did something, an 462 
internal policy, to enforce on everyone. We haven’t got a certification board or a re-licensing system 463 
so we made it part of our promotion criteria.”  464 
Challenge area #5: workforce planning 465 
In light of the concurrent surge in the number of pharmacy schools and the absence of workforce 466 
planning strategies,the ensuing growth in the workforce posed another concern for some pharmacists. 467 
A pharmacist who owns an independent pharmacy said: “Well this is what they call random planning! 468 
This is not acceptable really. At whose expense will this be? Will it be at the expense of the society? 469 
Or will it be at the expense of the pharmacy society later on? Or is it at the expense of quality the [of 470 
graduates]? What will happen when in the future the supply exceeds the demand?”Some insist 471 
thatcontrolling student intake be considered. A senior MoH pharmacist and researcher described 472 
this:“There are no accurate studies as to how many pharmacists Jordan needs. In the past, it used to 473 
be just the Bachelor degree and now we have the PharmD degree as well… Like I said there should 474 
be planning for the profession: a plan for how many students to teach and how many graduates we 475 
need.”According to one public pharmacy school dean, no new pharmacy schools should open;in 476 
describing this, he also highlightsan underlying issue regarding the JPA’s role in influencing 477 
pharmacy higher education policy:“It is best that we do stop [opening new schools]. From my 478 
knowledge and managerial experience, I don’t think it will work without pressure from the JPA. 479 
Unfortunately, the JPA is not practicing any regulatory role on education nor does it contribute to it; 480 
it has absolutely no relationship with education.”In contrast, other participants think that focusshould 481 
be turned to actively creating cross-sector job opportunities for pharmacists rather than controlling the 482 
supply-side. This is also the JPA’s view according to one spokesperson:“I’m not saying we should 483 
cap the number of students or reduce them, I’m not with that. Let them study pharmacy if they want to 484 
but I think we need to work more on creating job opportunities for them.”Contrasting but 485 
unsubstantiated views among participants also emerged on the workforce’s employment rate. On the 486 
one hand, some argued that the continued uncontrolled supply of pharmacists will exacerbate an 487 
already looming unemployment crisis. Opposing viewers deny an underlying problem in 488 
unemployment.  489 
Challenge area #6: remuneration and wage rate 490 
Participants report that pharmacists are routinely paid below the officially-stipulated rate by the JPA 491 
(≈$423-494 US Dollars/month for community pharmacists). A senior pharmacist in a private hospital 492 
described this: “I mean until now, there are pharmacists who take 150JDs [≈$211] especially in rural 493 
areas. If there was a strong syndicate, it would be able to enforce its laws through the Parliament and 494 
Ministry [of Labour], and then no one would dare overstep the pharmacist… The JPA shouldn’t allow 495 
transgressions on the salary issue. Pharmacists should be able to report on employers who pay less 496 
and the JPA should be ready to punish and enforce but you know how it is, it’s all connections and 497 
people knowing each other.” A training manager at a community pharmacy chain also discussed the 498 
issue of underpayment: “We hear a lot about people especially those working in the provinces whose 499 
salaries are 80, 90, or 120 JDs. So there is no good support from the JPA. I don’t feel at all that there 500 
is any support… There is a conflict of interest by those in charge of the JPA. I mean if I own a 501 
drugstore or a pharmacy I will influence many things.”The participant was referring the JPA’s 502 
organisational structure, in which the majority of the governing Council’s seats are reserved for 503 
pharmacy and drugstore owners; participants argue that, by making up part of the Council, business 504 
owners are thus positioned to influence policies in such a way that may not represent the best interests 505 
of the employed workforce. The business department head of a drugstore explains:“There are 506 
problems in the profession which stem from the JPA in my opinion. The profession here is politicized. 507 
I mean drugstore owners have a slice. Pharmacy owners have it too. Private pharmacies also have 508 
their own sector. So the profession starts from the top of the pyramid with those who are supposed to 509 
represent the profession and who, I believe, look out for their own personal interests - which is their 510 
main driver.”Both employees and employers have complained that the current minimum rate has 511 
been set arbitrarily and is too low in the context of rising prices and living costs. The chief executive 512 
officer of a pharmacy chain said: “The minimum salary is generally low… this is frustrating to many 513 
extents.”  514 
Challenge area #7: pharmacy assistants 515 
The seventh challenge area describes the issues reported about pharmacy assistants. The first is their 516 
deregulation. Besides the Diploma, pharmacy assistants aren’t required to complete any more 517 
requirements before practice, training or otherwise. Additionally, there is no registration body for 518 
pharmacy assistants and thus no practice license to be given. According to a participant from the 519 
MoH’s Health Professions and Licensing Directorate, pharmacy assistants were deregulated in 2000; 520 
the participant described the negative consequences of deregulating pharmacy assistants and indicated 521 
that it was fuelled by “professional politics”:“There used to be control before, whereby you couldn’t 522 
practice without approval from the Minister. Now all you need is to pass the examination. Whether 523 
you trained or not, no one can control you. The label ‘pharmacy assistant’ was dropped from the 524 
Public Health Act and the JPA’s Drug and Pharmacy Law. This is professional politics. They felt that 525 
the pharmacy assistant is an intruder into their profession.”Indeed, many pharmacists view pharmacy 526 
assistants in a negative light and consider them “intruders” onto the pharmacy profession; one 527 
independent pharmacy owner captures this shared sentiment:“We have a lot of intruders in the 528 
profession and these are the pharmacy assistants.”They described how professional boundaries are 529 
overstepped through the illegal dispensing of medicines by pharmacy assistants; while only registered 530 
pharmacists are allowed to dispense medicines,participants described how common it is to find 531 
pharmacy assistants not only dispensing to patients, but in some instances running pharmacies alone. 532 
An independent pharmacy owner describes this: “Legally they [pharmacy assistants] shouldn’t 533 
[dispense] but if you go around pharmacies after 5 pm, especially in the downtown, you wouldn’t find 534 
pharmacists. You would find pharmacy assistants.”The MoH’s licensing directorate employee raised 535 
another important notion: “Now let’s talk about who has real impact. Let’s assume doctors stopped 536 
working. The whole of Jordan would stop. The same goes for nurses. But if pharmacists were to stop 537 
working? Pharmacy assistants will simply replace them.”  538 
Challenge area #8: PharmD pharmacists 539 
The B.Sc. and the PharmDare viewed by the participants as two entry-level degrees in a practice 540 
environment that is essentially the same for both. The unclear role of PharmD graduates within the 541 
Jordanian national health system force many to share the same jobs of those with a B.Sc. One PharmD 542 
graduate described her own situation: “I am a PharmD graduate and there is no work in hospitals. 543 
PharmD, at the moment, is not active as a field. I don’t like to work in a pharmacy; I trained there 544 
and I didn’t like it. I wanted to work in a hospital but didn’t find one to work in. I tried being a 545 
medical representative but I didn’t like roaming around in the streets so I felt that this [regulatory 546 
affairs] is nice, but it has nothing to do with what we studied, absolutely nothing.” According to the 547 
participants, there are far less clinical and hospital positions than there are PharmD graduates. A 548 
representative of a national pharmacy student association posed the following: “How can you, as an 549 
educational provider, start a programme when you didn’t communicate with business owners to 550 
discuss job creation?” Additionally, interprofessional tension between physicians and pharmacists 551 
continues to form a barrier for the level of integration required for proper pharmaceutical care 552 
provision. A pharmacist manager at a sales and marketing company raised this issue:“Whoever 553 
suggested the PharmD programme… should have done full awareness campaigns to the hospitals so 554 
that each hospital knows the importance of the PharmD pharmacist and so the doctors themselves 555 
know that this is a partner: someone who will stand by your side and work with you. Until now, their 556 
view of them is quite bad.”There are ongoing efforts by the JPA to help secure permanent positions 557 
for some Pharm. D. graduates mainly through arranging temporary hospital posts in the hope of them 558 
becoming permanent and in some cases sharing the their wages with employers; a JPA spokesperson 559 
indicated that this has had positive effects so far: “Slowly once they [physicians] get used to them 560 
[pharmacists], they will realise that these pharmacists are good and that they help; then they won’t be 561 
able to dispense them. We’ve seen this happening in one of the hospitals. They started with 1 562 
[pharmacist] and now they have 10.”  563 
Focus group findings 564 
The eight main challenges affecting the state of the pharmacy profession in Jordan were validated 565 
with the study’s participants during the focus groups. The conceptual framework was used to identify 566 
the primary sectorial disconnect that was perceived by the participants to explain each challenge. 567 
Recommendations for solutions to each challengewere also proposed. Table 2 summarizes the 568 
validated challenges, agreed outcomes of the mapping exercise and lists the participants’ main 569 
recommendations for development.  570 
 571 
Summary of validated 
challenges Framework mapping outcome Recommendations for development 
1) Graduate skills gap and 
unpreparedness for practice 
Education-practice 
 Education providers to review and adjust the balance between theoretical and practical aspects 
of the curricula they teach.  
 Accreditors to re-evaluate current curricular standards and develop an outcome-based 
standards framework based on needs-based competencies. 
2) Shortcomings in higher 
education accreditation and 
quality assurance 
Regulation-education 
 Accreditors to review the current admissions processes and entry requirements of the PAD and 
PABP. 
 Accreditors to review the usability and flexibility of current curricular standards for the 
purposes of pharmacy programme development.  
3) Unregulated pre-
registration training and 
substandard licensing 
examination 
Regulation-practice 
 JPA to urgently establish atraining framework and introduce a structured penalties regime for 
noncompliant traineesand complicit pharmacists. 
 JPA to review the standards of the current pre-registration examination.  
4) Absence of workforce 
development and license 
revalidation systems 
Regulation-education 
 JPA to urgently establish a CPD standards framework ad push for the legislation of CPD 
requirements and, in due course, for continuing fitness to practice.  
5) Deficiencies in workforce 
planning and intelligence 
Education-practice 
 Education providers to collaborate with all stakeholders on creating cross-sector job 
opportunities for pharmacists. 
 JPA to establish workforce planning strategies and assess current and future supply and 
demand. 
6) Low and unmet 
pharmacists basic salaries 
Regulation-practice 
 JPA to introduce a structured penalties regime for non-compliant employers and consider 
implementing whistleblowing mechanisms.  
 JPA to review and assess the need to increase the current minimum wage rates.  
7) Loss of occupational 
control to pharmacy 
assistants  
Regulation-practice 
 JPA to urgently review enforcement of dispensing, pharmacy ownership and management 
laws are urgently called for.  
 JPA to consider creating clear national definitions of the roles of all pharmaceutical personnel. 
 JPA or/and MoH to urgently consider a reregulation drive for pharmacy assistants. 
8) Mismatch between job 
expectations and fulfilment 
for PharmD graduates 
Education-practice 
 Education providers tolead efforts in integrating graduates into the market and address any 
misapprehensions held by prospectivePharmD students over their future.  
Table 2Summary of the eight validated challenges, framework mapping outcomes and recommendations for development.572 
Discussion 573 
This study set out to identify and understand the current challenges facing the pharmacy profession in 574 
Jordan. The validation of thematically analysed interview data and their mappingusing conceptual 575 
framework that has been used in pharmacy
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resulted in eight main challenges spanning education, 576 
regulation and practice. (1) The unpreparedness of graduates for practice highlights a disconnect 577 
between educational outcomes and practice needs.(2) The inconsistencies of higher education 578 
accreditation and quality assurance mechanisms point toward a gap betweeneducational 579 
regulationsand their operationalisation in the respective educational institutions.(3) The extent to 580 
which pre-registration training is unregulated and unorganized is a result of a regulation- practice gap. 581 
(4) The absence of educational workforce development systems (i.e. CE and CPD) corresponds to a 582 
lack of regulatory policies on workforce education, hence a regulation-education gap. (5) The growing 583 
supply of the workforce coupled with unclear market demand are a symptom of a general lack of 584 
engagement between the educational and practice sectors. (6) The reported occurrence of community 585 
pharmacists being paid below their nationally stipulated minimum wages is traced to the ineffective 586 
enforcement of minimum wage regulations in practice. (7) The illegal dispensing by pharmacy 587 
assistants in community is another example of a regulation- practice gap. Finally, (8) the mismatch 588 
between the intended role of PharmD graduates and actual job fulfilment highlight anotherdisconnect 589 
between the education andpracticesectors. 590 
Most of the challenges are complex and the causal factors are multifaceted and could be traced to 591 
more than one, or all, of the three disconnections of the framework. This was illustrated by the 592 
different answers raised by the participants during the focus groups. For example, CPD/CE was also 593 
explained as a lack of workforce education in practice settings (education-practice gap), but it was 594 
eventually agreed that the absence of legal CPD/CE requirements of pharmacists merited 595 
prioritization (regulation-education gap).Collaborative efforts among the groups to simplify the 596 
explanations by reducing them to one disconnection axis per challenge were not meant to 597 
oversimplify the issues but rather facilitate prioritizing them; identifying a priority area for 598 
development within each of the themes allowed for a more streamlined process of formulating the 599 
most relevant recommendations.One example can be found in pre-registration requirements which 600 
include both the training and the examination, but the state of the unregulated training was prioritized 601 
over the examination’s standardand thus drove the mapping process and listing of the resultant 602 
recommendations.Recommendations and suggested solutions addressing – what were viewed to be 603 
secondary – sub-challenges were not excluded and are reported in the findings of this study (see Table 604 
2 above). In the case of the pre-registration requirements challenge, participants suggested that the 605 
JPA consider reviewing the current examination’s standards.The framework not only allowed us and 606 
the participants to conceptualize the challenges, but also to view them from multiple perspectives; in 607 
doing so, we were allowed to consider factors beyond those reported in the literature. 608 
The framework also highlights the importance of multi-sector engagement and collaboration in 609 
professional arenas.According to the framework, the separations between its components allow for 610 
checks and balancesbetween any two sectors and it is important that the separations don’t get too 611 
wide. The PharmD challenge in Jordan illustrates the effects of a separation that is too wide between 612 
education and practice. While it was reported that the programme’s addition to pharmacy education in 613 
Jordan was intended to expand the pharmaceutical care role of pharmacists in practice
32
, the practice 614 
environment – particularly in hospital settings – is not prepared for the uptake of hundreds of PharmD 615 
graduates according to the participants. A 2012 study stated that less than 5-10 institutions offered 616 
comprehensive pharmaceutical care services in Jordan.
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This was not taken into consideration when 617 
the PharmD – a degree originally designed for the North American practice settings – was first 618 
adopted by a public school. The controversy of the PharmD in Jordan is not surprising; the 619 
establishment of thePharmD model by a number of developing countries in Asia, Africa and the 620 
Middle East is not a new trend and Anderson et al. have describedthe downfalls of adopting a 621 
program that is not aligned with the local health care systems and population needs (i.e. needs-622 
based).
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Similarly, the unpreparedness of graduates for practice and their skill shortages also indicate 623 
an education-practice disconnect that points towards a general lack of a unified professional vision for 624 
education driven by and for all stakeholders.  625 
Another important aspect of the framework is its illustration of the limitations of professional self-626 
regulation.Where dual or multiple responsibilities are held in one sector, there is not the same 627 
motivation or incentive to look for changes and improvements. Instead, there is always the potential 628 
that ‘internal arguments’ – for and against any development or change– will tend to perpetuate the 629 
‘status quo’ instead of bringing about needed changes. This may explain the stagnation depicted in 630 
some of the challenges, especially those that fall under the responsibilities of the JPA. Participants 631 
reported that some of the challenges are not new and have remained unsolved for a long time, namely 632 
the lack of requirements forCPD/CE andthe unregulated pre-registration training. The conflict of 633 
interest inherent tothe JPA’s dual role as both regulatory and professional body, presents a situation in 634 
which patient safety is undermined pharmacists’ self-interests. Due to government pressure prompted 635 
by a series of national healthcare professional regulation failures, the United Kingdom’s former Royal 636 
Pharmaceutical Society of Great Britain (RPSGB) was split in 2010 into a professional leadership 637 
body (RPS) and the General Pharmaceutical Council (GPhC), a separate pharmacy regulatory and 638 
registration body. Earlier in 2004, New Zealand’s government legislated againsthealthcare 639 
professionals’ self-regulation, driving the split of the Pharmaceutical Society of New Zealand 640 
(PSNZ). These examples, coupled with the current situation in Jordan, demonstrate that a profession 641 
may be best served by the separation of its regulatory and registration functions on the one hand, and 642 
its representative and professional leadership function on the other.Despite it being considered one of 643 
the defining ‘traits’ of profession, self-regulation has always been subject to criticism – raising major 644 
accountability and conflict of interest concerns.
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On the other hand, it is argued that without 645 
‘competent’ self-regulation, true professional dominance cannot be assured.74The concept of 646 
achieving competence in self-regulation is, however, questionable in health professions where patient 647 
interests are constantly positioned to be weighed against the professionals’ own self-interests, and are 648 
thus bound to be sacrificed.  649 
Self-regulation highlights not only the limitations of the trait approach, but also those of the 650 
interactionist theoristswho place the power dynamics of professionals at the heart of their theories. 651 
The conceptual framework presented in this paper views the professional arena in terms of a list of 652 
three generic and broad sectors rather than focussing on‘interactions’, ‘functions’ or ‘definitions’. For 653 
example, the regulation component of the framework encompasses all and any parties with regulatory 654 
powers affecting the profession in question, be it self-regulatory or otherwise. This is an important 655 
aspect of the framework because it makes it complementary to the reprofessionalization paradigm. 656 
Holloway et al. point to the fact that reprofessionalization emphasizes and respects the “processual 657 
and conditional nature” of occupational control, as opposed to the unilinear approach traditional 658 
theories take in determining the once-and-for-all professional status of an occupation.
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 In turn, the 659 
structure of the framework and the dynamic relationships between its components respect and 660 
emphasize the processual nature of reprofessionalization. Another important aspect of the framework 661 
that lends it with an advantage over tradition theories of professionsis its ability to be contextualized 662 
andaccommodating of the varying characteristics of professional arenas. Any list of criteria borrowed 663 
from the trait theory for instance may not be work in more than one settings; a profession in one 664 
nation may not have a professional association, or a pre-licensing examination in the first place – in 665 
which case the trait theory will immediately disqualify it from the professionalization race. Indeed, 666 
the pharmacy community are warned from blindly relying on and supporting professional ideologies 667 
and professionalizing projects.
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 Efforts to do so may be deemed fruitless considering the lackof a 668 
universal consensus on what constitutes and defines a pharmacy profession;Traulson and Bissel 669 
instead rightly point out that pharmacy is in fact “embedded in the culture and the laws of the land 670 
where it is practiced”.12 671 
The study identified a number of significant challenges that require urgent consideration by all 672 
stakeholders in Jordan, and particularly by governmental, regulatory and professional bodies.Before 673 
developing a professional vision, the need for change must be recognised and accepted
77
, and the 674 
researchers hope to have succeeded in establishing a sense of urgency around the necessary changes 675 
that must be undertaken.The researchers hope that this study’s findings, and the resultant 676 
recommendations, will serve as a useful roadmap for informing and guiding current and future local 677 
professional initiatives and policymaking efforts. Further research into each of the issues identified is 678 
required to better understand and address them; local researchers and policymakers are therefore 679 
urged to consider formulating questions from the issues presented in this study and investigating them 680 
further. The researchers also urge regional and global researchers and stakeholders – particularly in 681 
developing countries where challenge-identification may be a challenge in and by itself – to employ 682 
the methodological approach used in this study in their respective contexts. The authors believe that 683 
the stakeholder-centric approach employed in conducting the research increased the validity and 684 
reliability of its conclusions, and the involvement of key policymakers increases the potential impact 685 
and implementation of the its findings and recommendations. In addition to the methodological design 686 
lending itself as a replicable example to pharmacy practice and health policy researchers, many of the 687 
issues highlighted in this study will have international resonance,thus potentially providing insights of 688 
value to health professions worldwide.  689 
Study limitations 690 
The researchers note that this study has several limitations. First, participant validation was found to 691 
be a logistically challenging method; the lead researcher, LRB,could only hold the focus groups on 692 
one particular day and this may have disallowed many participants from taking part. Despite the 693 
difficulty in re-engaging the entire original sample, the researchers believe that the cooperation of any 694 
number of original respondents is valuable. Second, the authors recognise that the sample of 695 
participants does not represent the total population of the pharmacy population; additionally the non-696 
recruitment of other stakeholder groups such as patients and other health care professionals may have 697 
affected the breadth of views presented. Therefore, caution should be used in drawing conclusions 698 
from the results of this study. The third limitation is related to data translation. Taking into account 699 
time and cost constraints, maximal measures were taken in this study to maximise the trustworthiness 700 
of the translation process, translating the source language to target language – particularly Arabic – is 701 
challenging and may have an impact on conceptual equivalence and this is an intrinsic limitation of 702 
cross-language research.
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  703 
Conclusion 704 
This paper has, for the first time, provided a holistic overview of the challenges facing the pharmacy 705 
profession in Jordan. It also presented a new conceptual framework that describes the relationship 706 
between three sectors of a professional arena: education, regulation and practice. The framework was 707 
used in a participant-centric study design to aid in understanding the challenges and devising 708 
appropriate recommendations for professional development. The frameworkwas found to not only be 709 
a practical and effective interpretive and formative toolfor research purposes, but also a modern and 710 
dynamic approach thatmay potentially redefinethe way professions are viewed and guidethe inevitable 711 
reprofessionalization processes necessary to the survival of health care professionals and their roles in 712 
ever-changing healthsystems.  713 
Acknowledgements 714 
The authors gratefully acknowledge Tom Gray whose critical reading of this manuscript has helped to 715 
improve and clarify it. Anas Bader and Saja Al Nahar are also thanked for their assistance in the 716 
transcription and translation of the data, respectively.  717 
 718 
  719 
1. Parsons T. The Professions and Social Structure. Soc Forces. 1939;17:457-467. 720 
2. Carr-Saunders AM, Wilson PA. The Professions. Oxford: The Clarendon Press; 721 
1933. 722 
3. Moran M, Wood B. State, Regulation and the Medical Profession. Buckingham: Open 723 
University Press; 1993. 724 
4. Saks M. Professionalism in Health Care. In: Field D, Taylor S, eds. Sociological 725 
Perspectives on Health, Illness and Health Care. Great Britain: Blackwell Science 726 
Ltd; 1998. 727 
5. Johnson TJ. Professions and Power. London: Macmillan; 1972. 728 
6. Wilding P. Professional Power and Social Welfare. London: Routledge; 1982. 729 
7. Freidson E. Theory and the Professions. Indiana Law J. 1989;64:423-432. 730 
8. Brante T. Sociological Approaches to the Professions. Acta Sociol. 1988;31:119-142. 731 
9. Freidson E. Profession of Medicine: A Study of the Sociology of Applied Knowledge. 732 
1988 ed. United States of America: University of Chicago Press; 1970. 733 
10. Haug MR. Deprofessionalization: An Alternate Hypothesis for the Future. Sociol Rev. 734 
1972;20:195-211. 735 
11. Toren N. Deprofessionalization and its Sources: A Preliminary Analysis. Work Occup. 736 
1975;2:323-337. 737 
12. Traulsen JM, Bissel P. (9) Theories of professions and the pharmacist. Int J Pharm 738 
Pract. 2004;12:107-114. 739 
13. Wilensky HL. The Professionalization of Everyone? Am J Sociol. 1964;70:137-158. 740 
14. Hepler CD. Pharmacy as a clinical profession. Am J Hosp Pharm. 1985;42:1298-741 
1306. 742 
15. International Pharmaceutical Federation. From Making Medicines to Optimising 743 
Outcomes: The evolution of a profession 1912-2012. 2012. 744 
16. Holland RW, Nimmo CM. Transitions, part 1: beyond pharmaceutical care. Am J 745 
Health Syst Pharm. 1999;56:1758-1764. 746 
17. Denzin NK, Mettlin CJ. Incomplete Professionalization: The Case of Pharmacy. Soc 747 
Forces. 1968;46:375-381. 748 
18. Hepler CD, Strand LM. Opportunities and responsibilities in pharmaceutical care. 749 
American journal of hospital pharmacy. 1990;47:533-543. 750 
19. Dingwall R, Wilson E. Is Pharmacy Really an "Incomplete Profession"? Perspect Soc 751 
Prob. 1995;7:111-128. 752 
20. Edmunds J, Calnan MW. The reprofessionalisation of community pharmacy? An 753 
exploration of attitudes to extended roles for community pharmacists amongst 754 
pharmacists and General Practioners in the United Kingdom. Soc Sci Med. 755 
2001;53:943-955. 756 
21. Bush J, Langley CA, Wilson KA. The corporatization of community pharmacy: 757 
Implications for service provision, the public health function, and pharmacy's claims 758 
to professional status in the United Kingdom. Res Soc Adm Pharm. 2009;5:305-318. 759 
22. McDonald R, Cheraghi-Sohi S, Sanders C, Ashcroft D. Professional status in a 760 
changing world: The case of medicines use reviews in English community pharmacy. 761 
Soc Sci Med. 2010;71:451-458. 762 
23. Birenbaum A. Reprofessionalization in pharmacy. Soc Sci Med. 1982;16:871-878. 763 
24. Gilbert L. Pharmacy's attempts to extend its roles: A case study in South Africa. Soc 764 
Sci Med. 1998;47:153-164. 765 
25. Awalom MT, Tesfa AF, Kidane ME, Ghebremedhin MR, Teklesenbet AH. Eritrean 766 
pharmacists' job satisfaction and their attitude to re-professionalize pharmacy in to 767 
pharmaceutical care. Int J Clin Pharm. 2015;37:335-341. 768 
26. Birenbaum A, Bologh R, Lesieur H. Reforms in pharmacy education and opportunity 769 
to practise clinical pharmacy. Sociol. Health Illn. 1987;9:286-301. 770 
27. Babar Z-U-D, Scahill SL, Akhlaq M, Garg S. A bibliometric review of pharmacy 771 
education literature in the context of low- to middle-income countries. Currents in 772 
Pharmacy Teaching and Learning. 2013;5:218-232. 773 
28. Gallagher RM, Gallagher HC. Improving the working relationship between doctors 774 
and pharmacists: is inter-professional education the answer? Advances in Health 775 
Sciences Education. 2010;17:247-257. 776 
29. Williams KF. Re-examining 'professionalism' in pharmacy: a South African 777 
perspective. Soc Sci Med. 2007;64:1285-1296. 778 
30. Wafula F, Abuya T, Amin A, Goodman C. The policy-practice gap: describing 779 
discordances between regulation on paper and real-life practices among specialized 780 
drug shops in Kenya. BMC Health Serv. Res. 2014;14:394. 781 
31. Annandale E. The Sociology of Health and Medicine. Second Edition ed. Great 782 
Britain: Polity Press; 2014. 783 
32. Al-Wazaify M, Albsoul-Younes A. Pharmacy in Jordan. Am J Health Syst Pharm. 784 
2005;62:2548-2551. 785 
33. Jordan Pharmacists Association. Drug and Pharmacy Law 2001. 2001. 786 
34. Higher Education Accreditation Commission. Accredited Programmes. 2015; 787 
http://www.heac.org.jo/?page_id=2178. Accessed 6 September, 2015. 788 
35. World Health Organisation. WHO Medicines Survey in Jordan To Measure Access to 789 
and Use of Medicines in Jordan. Ministry of Health, Jordan2012. 790 
36. Alsharif MJ, Labonté R, Zuxun Lu. Patients beyond borders: A study of medical 791 
tourists in four countries. Glob Soc Policy. 2010;10:315-335. 792 
37. Sharabati AAA, Jawad SN, Bontis N. Intellectual capital and business performance in 793 
the pharmaceutical sector of Jordan. Manag Decis. 2010;48:105-131. 794 
38. Jordan Pharmacists Association. Amman, Jordan2015. 795 
39. Issa A, Farha RA, Elayeh E, Bustanji Y. The Impact of Lack of Pharmacist 796 
Contribution on the Prescription Patterns and the Appropriateness of Indications of 797 
NSAIDs : A Cross-Sectional Study. Jordan J Pharm Sci. 2013;6:258-269. 798 
40. Aburuz S, Al-Ghazawi M, Snyder A. Pharmaceutical care in a community-based 799 
practice setting in Jordan: where are we now with our attitudes and perceived 800 
barriers? Int J Pharm Pract. 2012;20:71-79. 801 
41. Tahaineh LM, Wazaify M, Albsoul-Younes A, Khader Y, Zaidan M. Perceptions, 802 
experiences, and expectations of physicians in hospital settings in Jordan regarding 803 
the role of the pharmacist. Res Soc Adm Pharm. 2009;5:63-70. 804 
42. Al Khalidi D, Wazaify M. Assessment of pharmacists' job satisfaction and job related 805 
stress in Amman. Int J Clin Pharm. 2013;35:821-828. 806 
43. Wazaify M, Al-Bsoul-Younes A, Abu-Gharbieh E, Tahaineh L. Societal perspectives 807 
on the role of community pharmacists and over-the-counter drugs in Jordan. Pharm 808 
World Sci. 2008;30:884-891. 809 
44. Alenezi NA, Wazaify MM, Albsoul-Younes A. Evaluation of outpatient-pharmacists' 810 
counseling behavior and content in a teaching hospital in jordan- An observational 811 
study. Jordan J Pharm Sci. 2014;7:77-87. 812 
45. Yousef AM, Al-Bakri AG, Bustanji Y, Wazaify M. Self-medication patterns in Amman, 813 
Jordan. Pharm World Sci. 2008;30:24-30. 814 
46. Shehadeh M, Suaifan G, Darwish RM, Wazaify M, Zaru L, Alja’fari S. Knowledge, 815 
attitudes and behavior regarding antibiotics use and misuse among adults in the 816 
community of Jordan. A pilot study. Saudi Pharm J. 2012;20:125-133. 817 
47. Mason J. Qualitative Researching. London: Sage; 1996. 818 
48. Almarsdottir AB, Traulsen JM. Multimethod research into policy changes in the 819 
pharmacy sector--the Nordic case. Res Soc Adm Pharm. 2009;5:82-90. 820 
49. Barbour RS. Checklists for improving rigour in qualitative research: a case of the tail 821 
wagging the dog? BMJ. 2001;322:1115-1117. 822 
50. Biernacki P, Waldorf D. Snowball Sampling: Problems and Techniques of Chain 823 
Referral Sampling. Soc Methods Res. 1981;10:141-163. 824 
51. Britten N. Qualitative interviews in medical research. BMJ. 1995;311:251-253. 825 
52. DiCicco-Bloom B, Crabtree BF. The qualitative research interview. Med. Educ. 826 
2006;40:314-321. 827 
53. Wall C, Glenn S, Mitchinson S, Poole H. Using a reflective diary to develop 828 
bracketing skills during a phenomenological investigation. Nurse Res. 2004;11:20-29. 829 
54. Horsburgh D. Evaluation of qualitative research. J. Clin. Nurs. 2003;12:307-312. 830 
55. Jasper MA. Using reflective writing within research. J. Res. Nurs. 2005;10:247-260. 831 
56. Ortlipp M. Keeping and using reflective journals in the qualitative research process. 832 
The Qualitative Report. 2008;13:695-705. 833 
57. Long T, Johnson M. Rigour, reliability and validity in qualitative research. Clin Eff 834 
Nurs. 2000;4:30-37. 835 
58. Morse JM. The Significance of Saturation. Qual. Health Res. 1995;5:147-149. 836 
59. Squires A. Methodological Challenges in Cross-Language Qualitative Research: A 837 
Research Review. Int. J. Nurs. Stud. 2009;46:277-287. 838 
60. Al-Amer R, Ramjan L, Glew P, Darwish M, Salamonson Y. Translation of interviews 839 
from a source language to a target language: examining issues in cross-cultural 840 
health care research. J. Clin. Nurs. 2015;24:1151-1162. 841 
61. Brislin RW. Back-Translation for Cross-Cultural Research. J. Cross Cult. Psychol. 842 
1970;1:185-216. 843 
62. Chen HY, Boore JR. Translation and back-translation in qualitative nursing research: 844 
methodological review. J. Clin. Nurs. 2010;19:234-239. 845 
63. Braun V, Clarke V. Using thematic analysis in psychology. Qualitative Research in 846 
Psychology. 2006;3:77-101. 847 
64. Frisina A. Back-talk Focus Groups as a Follow-Up Tool in Qualitative Migration 848 
Research: The Missing Link? Forum Qual Soc Res. 2006;7. 849 
65. Mays N, Pope C. Assessing quality in qualitative research. BMJ. 2000;320:50-52. 850 
66. Krefting L. Rigor in qualitative research: the assessment of trustworthiness. Am J 851 
Occup Ther. 1991;45:214-222. 852 
67. Lincoln YS, Guba EG. Naturalistic Enquiry. Newbury Park, CA: Sage; 1985. 853 
68. Torrance H. Triangulation, Respondent Validation, and Democratic Participation in 854 
Mixed Methods Research. Journal of Mixed Methods Research. 2012;6:111-123. 855 
69. Wheeldon J, Faubert J. Framing Experience: Concept Maps, Mind Maps, and Data 856 
Collection in Qualitative Research Int J Qual Methods. 2009;8:68-83. 857 
70. International Pharmaceutical Federation. Quality Assurance of Pharmacy Education: 858 
the FIP Global Framework. The Hague, The Netherlands: International 859 
Pharmaceutical Federation;2014. 860 
71. AbuRuz SM, Al-Ghazawi MA, Bulatova N, Jarab AS, Alawwa IA, Al-Saleh A. 861 
Expectations and experiences of physicians regarding pharmaceutical care and the 862 
expanding role of pharmacists in Jordan. Jordan J Pharm Sci. 2012;5:74-85. 863 
72. Anderson C, Futter B. PharmD or Needs Based Education: Which Comes First? Am 864 
J Pharm Educ. 2009;73:92. 865 
73. Ogus A. Rethinking Self-Regulation. Oxf J Leg Stud. 1995;15:97-108. 866 
74. Irvine D. The performance of doctors. I: Professionalism and self regulation in a 867 
changing world. BMJ : British Medical Journal. 1997;314:1540-1542. 868 
75. Holloway SWF, Jewson ND, Mason DJ. ‘Reprofessionalization’ or ‘occupational 869 
imperialism’?: Some reflections on pharmacy in Britain. Soc Sci Med. 1986;23:323-870 
332. 871 
76. Almarsdóttir AB, Kaae S, Traulsen JM. Opportunities and challenges in social 872 
pharmacy and pharmacy practice research. Res Soc Adm Pharm. 2014;10:252-255. 873 
77. Tsuyuki RT, Schindel TJ. Changing Pharmacy Practice: The Leadership Challenge. 874 
Can Pharm J. 2008;141:174-180. 875 
78. Al-Amer R, Ramjan L, Glew P, Darwish M, Salamonson Y. Language translation 876 
challenges with Arabic speakers participating in qualitative research studies. Int. J. 877 
Nurs. Stud. 2016;54:150-157. 878 
 879 
 880 
List of Figures 881 
Figure 1 A conceptual framework depicting the dynamic relationships between practice, regulation 882 
and education. (International Pharmaceutical Federation 2014, adapted with permission) .................... 8 883 
 884 
List of Tables 885 
Table 1 Sector distribution of study participants. ................................................................................. 14 886 
Table 2 Summary of the eight validated challenges, framework mapping outcomes and 887 
recommendations for development. ...................................................................................................... 30 888 
  889 
Appendix 1 890 
Semi-structured interview guide 
1. Tell me about the nature of your practice and your role.What challenges do you face in 
your practice setting? 
2. What are your thoughts on pharmacy education in Jordan? What do you think of the quality 
of graduates? What skills or competencies do they lack, if any?What changes, if any, would 
you like to see in pharmacy education in Jordan? 
3. With regards to your practice, what are your thoughts on the regulation of pharmacy? What 
challenges do you face? What changes would you like to see in regulation? 
4. What do you think of the regulatory role of the JPA? What do you think of the JPA as a 
professional body? Do you perceive the JPA to be carrying its responsibilities effectively? 
If not, why? 
5. Generally speaking, what do you think of the overall status of the profession here in 
Jordan? Why? 
6. What challenges do you think it faces? How do they affect you in your practice? 
7. How do you think those challenges should be addressed?Who should be responsible for 
addressing them? 
8. What is the most important change that you want to see in the profession? Why? 
  891 
Appendix 2 892 
Focus group guide 
Opening question 1. I’d like to start by briefly telling you what we did with your interviews 
and how we used them to identify 8 challenges the research team 
believes to be facing the pharmacy profession in Jordan and negatively 
impacting on its overall advancement.  
Validation phase 
questions 
2. I want to discuss with you the validity of our findings. We’ve asked you 
to come today so you can help us. Your participation is vital to the final 
conclusions of the study and I would like your full input. We are 
especially keen on hearing any opposing views or constructive 
criticisms which will only help us to further refine the results and 
improve the study. 
3. What do you think of challenge X?Do you think it’s true? Does it 
accurately reflect the situation? 
4. Do you think it doesn’t represent the situation? How? Do you disagree 
with it? Why? 
5. Do you perceive X as a challenge facing the pharmacy profession in 
Jordan? Do you think that this challenge is affecting the overall 
advancement of the profession? How? If this challenge is addressed, do 
you think the profession would be in a better state? 
6. Do you think there are other major challenges that are not described by 
this list? 
Transition question 7. Now that we’ve validated the challenges, I would like to tell you about 
a conceptual framework that we can use to help us better understand 
each challenge and discuss ways of addressing it.  
Mapping phase 
questions 
8. On the piece of paper with an illustration of the framework in front of 
you, please take as much time as you need to assign each of the 8 
challenges to the axis you perceive to be the main cause of the 
challenge. More than one may apply, but please try to assign it to what 
you perceive to be the primary one.  
9. Regarding challenge X, who perceived the challenge to be related to a 
disconnect between education-regulation?Regulation-practice? 
Practice-education? Why? 
10. Do you all agree that challenge X is primarily related to disconnect Y? 
If not, why? 
11. The research team initially assigned challenge X to disconnect Y-Y 
because they thought the reason is Z. What do you think of their 
interpretation? 
12. How do you think challenge X can be addressed? What solutions do 
you perceive to be appropriate? What recommendations do you have? 
Ending questions 13. We hope to publish the final results of this study. Do you think the 
results may have an impact on pharmacy in Jordan? Do you think you 
or other stakeholders would use this information? 
14. Finally, is there anything else you would like to say? 
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